Previous 10 | Next 10 |
MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2021. Record second quarter revenue reflects continued quarter-over-quarter growth Revenue for the seco...
Pacific Biosciences of California (NASDAQ:PACB) has acquired Maryland-based biotechnology company Circulomics. Scientists recognize Circulomics as a leader in extracting high quality, high molecular weight (HMW) DNA from almost any sample type, the company said. The financial t...
MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, long-read sequencing platforms, announced today that it acquired Circulomics ...
AFG, AIZ, AKAM, AMGN, APAM, ATVI, AYX, BKH, BLKB, BNFT, CAR, CDLX, COUR, CW, CZR, DCPH, DEI, DENN, DK, DVA, DVN, ET, EVTC, FICO, FMC, FNF, FRG, GBT, GDOT, H, HPP, HST, ICFI, ICHR, INFN, INSP, IOSP, JAZZ, KAI, KAR, KFRC, KTOS, KWR, LPSN, LSCC, LSI, LYFT, LYV, MANT, MGRC, MRCY, MTCH, MYGN, NBIX...
Pacific Biosciences of California (PACB) gains 2.5% premarket after signing a merger agreement to acquire Omniome, a San Diego-based company developing a highly differentiated short-read sequencing platform capable of delivering high accuracy. Under the terms of the agreement, PacBi...
Collaboration to develop production-scale HiFi Sequencing platform expected to Include technology from Omniome, Inc. Combining both highly accurate long and short read sequencing technologies expected to provide deeper clinical insights and lower the overall cost of an...
Combination aims to transform the genomics landscape and deliver a differentiated product offering into high growth clinical markets Brings together Omniome’s high accuracy short-read sequencing platform, with PacBio’s market leading, high accuracy long-read so...
MENLO PARK, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its second quarter 2021 financial results on Tuesday, August 3, 2021, at 4:30pm Eastern Time. The call will be webcast and ma...
Hot Gene Editing Stocks To Watch In The Stock Market Today Finding the best stocks to invest in 2021 is all about understanding the stock market trajectory. With the healthcare space undergoing a genomics revolution, gene editing stocks have been in focus. For those unfamili...
Baker Brothers’ 13F portfolio value decreased from $26.54B to $23.07B this quarter. The large stake in Alexion Pharmaceuticals was decreased during the quarter. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almost ~57% of the portfol...
News, Short Squeeze, Breakout and More Instantly...
Pacific Biosciences of California Inc. Company Name:
PACB Stock Symbol:
NASDAQ Market:
Pacific Biosciences of California Inc. Website:
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
MENLO PARK, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that Novogene is using its Revio long-read sequencing system to expand the capabilities of its new lab in Munich, Germany, se...
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...